• Home
  • Clinical Need
  • Technology
  • Team
  • News
  • More
    • Home
    • Clinical Need
    • Technology
    • Team
    • News
  • Home
  • Clinical Need
  • Technology
  • Team
  • News

Mar 16, 2025 Laplace Interventional: $22M Series C Fundraise

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

November 24, 2024 Dr. Kashish Goel presents on Laplace TTVR System at PCR London Valves

Laplace Interventional Inc. Announces Series C Financing of $22M for its Transcatheter Tricuspid Valve Technology

See Entire Press Release

November 24, 2024 Dr. Kashish Goel presents on Laplace TTVR System at PCR London Valves

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

November 24, 2024 Dr. Kashish Goel presents on Laplace TTVR System at PCR London Valves

See Entire Presentation

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

See Entire Presentation

June 6, 2024 Dr. Thomas Waggoner presents on Laplace TTVR System FIH results at New York Valves 2024

June 6, 2024 Dr. Thomas Waggoner presents on Laplace TTVR System FIH results at New York Valves 2024

October 28, 2024 Dr. Pradeep Yadav presents on Laplace TTVR System Early Feasibility results at TCT

See Entire Presentation

Feb 26, 2024 Laplace Interventional begins the US EFS of their TTVR system

June 6, 2024 Dr. Thomas Waggoner presents on Laplace TTVR System FIH results at New York Valves 2024

Feb 26, 2024 Laplace Interventional begins the US EFS of their TTVR system

Laplace Interventional Inc. Announces Successful First in Human Procedure in Early Feasibility Study of its Transcatheter Tricuspid Valve Replacement Device. 

See Entire Press Release

July 24, 2023 Laplace Interventional: $12.9M Series B Fundraise

June 6, 2024 Dr. Thomas Waggoner presents on Laplace TTVR System FIH results at New York Valves 2024

Feb 26, 2024 Laplace Interventional begins the US EFS of their TTVR system

The Series B financing was co-led by ShangBay Capital along with Features Capital in addition to participation from Engage Venture Partners, JWC Ventures and a global strategic investor. Laplace Interventional plans to use the funds raised from this round to pursue their First-in-Human (FIH) and clinical feasibility evaluation of its transcatheter valve system.

See Entire Press Release

Sep 1, 2021: Laplace Interventional: $7.9M Series A Fundraise

Sep 1, 2021: Laplace Interventional: $7.9M Series A Fundraise

Sep 1, 2021: Laplace Interventional: $7.9M Series A Fundraise

The Series A was led by a major strategic investor along with a significant investment from ShangBay Capital as well as other investors. Laplace Interventional plans to use the funds raised from this round towards achieving its preclinical milestones.

See Entire Press Release

Caution: Laplace Interventional's TTVR system is for investigational use only and is NOT currently available for sale in US or any other geography.

Copyright © 2025 Laplace Interventional - All Rights Reserved.

  • Home

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept